BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4403917)

  • 21. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Pharmacological studies with LL 21-945, a new beta-adrenoceptor blocking agent with a long duration of action.
    Clark BJ; Saameli K; Troxler F
    Br J Pharmacol; 1974 Sep; 52(1):123P. PubMed ID: 4155983
    [No Abstract]   [Full Text] [Related]  

  • 23. The central action of drugs influencing beta-adrenergic receptor. part V. The interaction of drugs affecting beta-adrenergic receptor in motility test.
    Ksiaz A; Kleinrok Z
    Pol J Pharmacol Pharm; 1975; 27(6):595-601. PubMed ID: 1714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cholinergic antagonism by beta-blockers. I. Spectrum of interactions].
    Re L; Giorgetti F; Rossini L
    Boll Soc Ital Biol Sper; 1980 May; 56(9):892-8. PubMed ID: 6108773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
    Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
    [No Abstract]   [Full Text] [Related]  

  • 30. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac effects of beta-adrenergic receptor antagonists.
    Ablad B; Carlsson B; Carlsson E; Dahlöf C; Ek L; Hultberg E
    Adv Cardiol; 1974; 12(0):290-302. PubMed ID: 4151859
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.
    Ablad B; Carlsson E; Ek L
    Life Sci I; 1973 Feb; 12(3):107-19. PubMed ID: 4144510
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 35. [Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers].
    Imai H; Niwa M; Nozaki M; Tsurumi K; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):13-20. PubMed ID: 6133820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

  • 37. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR; Commarato MA
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract]   [Full Text] [Related]  

  • 38. [Inotropic effects of several adrenergic beta blockers in a dog subjected to electrosystolic cardiac impulse].
    Cheymol G; Mouillé P; Schmitt H; Laubie M
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):45-51. PubMed ID: 4148408
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative effects of several beta-adrenergic inhibitors on pulmonary resistance in guinea pigs].
    Giudicelli JF; Boissier JR; Dumas Y; Advenier C
    C R Seances Soc Biol Fil; 1973; 167(2):232-7. PubMed ID: 4153959
    [No Abstract]   [Full Text] [Related]  

  • 40. [Beta adrenergic drugs in arterial hypertension].
    Gysling E
    Union Med Can; 1972 Jul; 101(7):1336-41. PubMed ID: 4402882
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.